Shell Asset Management CO Arrowhead Pharmaceuticals, Inc. Transaction History

Shell Asset Management CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$29.63 - $48.31 $45,067 - $73,479	-1,521 Reduced 20.83%	5,781 $191,000
Q2 2022 Aug 09, 2022	BUY	$27.79 - $50.61 $68,196 - $124,196	2,454 Added 50.62%	7,302 $257,000
Q1 2022 May 04, 2022	SELL	$39.62 - $69.97 $28,447 - $50,238	-718 Reduced 12.9%	4,848 $223,000
Q4 2021 Feb 09, 2022	BUY	$58.09 - $82.51 $2,091 - $2,970	36 Added 0.65%	5,566 $369,000
Q3 2021 Nov 04, 2021	SELL	$58.38 - $84.96 $14,011 - $20,390	-240 Reduced 4.16%	5,530 $345,000

Q2 2021 Aug 12, 2021	BUY	$62.15 - $90.32 $19,266 - $27,999	310 Added 5.68%	5,770 $478,000
Q1 2021 May 10, 2021	SELL	$61.35 - $90.47 $1,840 - $2,714	-30 Reduced 0.55%	5,460 $362,000
Q2 2020 Aug 10, 2020	SELL	$26.12 - $43.27 $2,037 - $3,375	-78 Reduced 1.4%	5,490 $237,000
Q1 2020 May 11, 2020	SELL	$20.56 - $63.12 $1,747 - $5,365	-85 Reduced 1.5%	5,568 $160,000
Q4 2019 Feb 13, 2020	SELL	$28.14 - $73.01 $3,939 - $10,221	-140 Reduced 2.42%	5,653 $359,000
Q3 2019 Nov 12, 2019	SELL	$26.26 - $34.86 $1,313 - $1,743	-50 Reduced 0.86%	5,793 $163,000
Q2 2019 Aug 12, 2019	BUY	$17.43 - $28.82 $101,843 - $168,395	5,843 New	5,843 $155,000

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.